Coelho Rogerio Vivaldi's Net Worth
$3.71 Million
Who is Coelho Rogerio Vivaldi?
Coelho Rogerio Vivaldi has an estimated net worth of $3.71 Million. This is based on reported shares across multiple companies, which include Crinetics Pharmaceuticals, Inc., Spark Therapeutics, Inc., Sigilon Therapeutics, Inc., Minerva Neurosciences, Inc., Bioverativ Inc., and Viatris Inc.
SEC CIK
Coelho Rogerio Vivaldi's CIK is 0001610381
Past Insider Trading and Trends
2016 was Coelho Rogerio Vivaldi's most active year for acquiring shares with 8 total transactions. Coelho Rogerio Vivaldi's most active month to acquire stocks was the month of January. 2016 was Coelho Rogerio Vivaldi's most active year for disposing of shares, totalling 11 transactions. Coelho Rogerio Vivaldi's most active month to dispose stocks was the month of September. 2022 saw Coelho Rogerio Vivaldi paying a total of $1,552,400.00 for 698,750 shares, this is the most they've acquired in one year. In 2015 Coelho Rogerio Vivaldi cashed out on 142,333 shares for a total of $3,158,400.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Crinetics Pharmaceuticals, Inc. (CRNX) Snapshot price: $50.39
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +30.91% | 3.4K |
—
|
—
| 14.4K |
Jun 7
| |||
Form 4
| +120.00% | 6K |
—
|
—
| 11K |
Jun 16
| |||
Form 4
|
∞
| 5K |
$22.06 | $110,300.00 | 5K |
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Spark Therapeutics, Inc. No price found
Chief Commercial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$29.69 | -$326,824.00 | 18.72K |
Scheduled
|
Jul 15
| ||
Form 4
|
—
|
0
|
$23.18 | -$235,740.00 | 18.72K |
Scheduled
|
Apr 20 - Apr 21
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
| +247.69% | 13.33K |
$27.83 | -$875,602.50 | 18.72K |
Oct 13
| |||
Form 4
| -15.67% | -1.00K |
$27.67 | -$1,743,300.00 | 5.38K |
Oct 7
| |||
Form 4
| +64.38% | 2.5K |
$23.00 | $57,500.00 | 6.38K |
Feb 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Sigilon Therapeutics, Inc. No price found
PRESIDENT AND CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -12.17K |
—
|
—
|
0
|
Aug 11
| |||
Form 4
| +85.91% | 5.53K |
$19.24 | $106,358.72 | 11.96K |
Jul 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
| +213.12% | 50K |
—
|
—
| 73.46K |
Nov 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 11
| |||
Form 4
|
∞
| 22.22K |
—
|
—
| 22.22K |
Dec 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Minerva Neurosciences, Inc. (NERV) Snapshot price: $2.65
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
∞
| 41.67K |
$6.00 | $250,002.00 | 41.67K |
Jun 30 - Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Bioverativ Inc. No price found
EVP, Chief Global Therapeutics
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -5.76K |
—
|
—
|
0
|
Mar 8
| |||
Form 4
| +1,583.06% | 4.99K |
$103.52 | -$220,083.52 | 5.3K |
Feb 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||